Brookline, MA, United States of America

Fumito Ichinose

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 84(Granted Patents)


Company Filing History:


Years Active: 2003-2016

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Fumito Ichinose: Innovator in Neurodegenerative Disease Treatment

Introduction

Fumito Ichinose is a prominent inventor based in Brookline, MA (US). He has made significant contributions to the field of medicine, particularly in the treatment of neurodegenerative diseases. With a total of 4 patents to his name, Ichinose continues to push the boundaries of medical innovation.

Latest Patents

Ichinose's latest patents include groundbreaking work on compositions and methods to treat neurodegenerative diseases. This specification provides innovative solutions aimed at addressing the complexities of these conditions. Another notable patent focuses on the attenuation of vasoactive oxygen carrier-induced vasoconstriction. This patent discloses compositions and methods for preventing or reducing vasoconstriction in mammals following the administration of an artificial oxygen carrier, such as a hemoglobin-based oxygen carrier. The methods involve administering a composition that includes an artificial oxygen carrier in combination with various therapeutic agents.

Career Highlights

Fumito Ichinose is affiliated with The General Hospital Corporation, where he has been instrumental in advancing research and development in his field. His work has garnered attention for its potential to improve patient outcomes in neurodegenerative diseases.

Collaborations

Ichinose has collaborated with esteemed colleagues, including Warren M Zapol and Kenneth D Bloch. These partnerships have further enriched his research and contributed to the success of his innovative projects.

Conclusion

Fumito Ichinose stands out as a key figure in the realm of medical innovation, particularly in the treatment of neurodegenerative diseases. His patents reflect a commitment to improving healthcare through scientific advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…